RecruitingNot ApplicableNCT06851130

Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women

Sponsor

Swiss Federal Institute of Technology

Enrollment

120 participants

Start Date

Feb 25, 2025

Study Type

INTERVENTIONAL

Conditions

Iron Deficiency (Without Anemia)

Summary

Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying ferrous sulfate 160 mg and ferrous sulfate 80 mg for people with iron deficiency (without anemia). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTferrous sulfate 80 mg

1 tablet per day

DIETARY_SUPPLEMENTferrous sulfate 160 mg

2 tablets per day

Locations(1)

Laboratory of Nutrition and Metabolic Epigenetics

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06851130

Related Trials

Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency

NCT073949721 location